DATATRAK adds Triangle Biostatistics to Connect Partner Program

DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the addition of Triangle Biostatistics, LLC. to its Connect Partner Program. The partnership will extend the reach of DATATRAK Clinical and Consulting Services™ (DCCS) to enable customers to receive strong statistical consulting and programming support from experienced industry professionals.

"We are excited about working with DATATRAK's Clinical and Consulting Services to expand the offerings to their clients," said Dr. Charles Wakeford, Managing Member of Triangle Biostatistics. "By combining efforts, the partnership will provide statistical consulting and programming services to the DATATRAK customers."

"This partnership will allow DCCS to expand its services offering," said Dr. Bill Gluck, DATATRAK's Vice President of Clinical and Consulting Services. "Having Triangle Biostatistics as part of the Connect Partner Program is an invaluable resource to the DATATRAK customer community; we are thrilled about this partnership."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers open ‘window to the brain’ with powerful cancer tech